Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation.

Zhangting Wang, Jiang Ma, Sheng Yao, Yisheng He, Kai-Kei Miu, Qingsu Xia, Peter P Fu, Yang Ye, Ge Lin
Author Information
  1. Zhangting Wang: School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  2. Jiang Ma: School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  3. Sheng Yao: State Key Laboratory of Drug Research and Natural Products Chemistry Department, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  4. Yisheng He: School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  5. Kai-Kei Miu: School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  6. Qingsu Xia: National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States.
  7. Peter P Fu: National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States.
  8. Yang Ye: State Key Laboratory of Drug Research and Natural Products Chemistry Department, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  9. Ge Lin: School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

Abstract

Misuse of pyrrolizidine alkaloid (PA)-containing plants or consumption of PA-contaminated foodstuffs causes numerous poisoning cases in humans yearly, while effective therapeutic strategies are still limited. PA-induced liver injury was initiated by cytochrome P450 (CYP)-mediated metabolic activation and subsequent formation of adducts with cellular proteins. Liquorice, a hepato-protective herbal medicine, is commonly used concurrently with PA-containing herbs in many compound traditional Chinese medicine formulas, and no PA-poisoning cases have been reported with this combination. The present study aimed to investigate hepato-protective effects of liquorice aqueous extract (EX) and 18β-glycyrrhetinic acid (GA, the primary bioactive constituent of liquorice) against PA-induced hepatotoxicity and the underlying mechanism. Histopathological and biochemical analysis demonstrated that both single- and multiple-treatment of EX (500 mg/kg) or GA (50 mg/kg) significantly attenuated liver damage caused by retrorsine (RTS, a representative hepatotoxic PA). The formation of pyrrole-protein adducts was significantly reduced by single- (30.3% reduction in liver; 50.8% reduction in plasma) and multiple- (32.5% reduction in liver; 56.5% reduction in plasma) treatment of GA in rats. Single- and multiple-treatment of EX also decreased the formation of pyrrole-protein adducts, with 30.2 and 31.1% reduction in rat liver and 51.8 and 53.1% reduction in rat plasma, respectively. In addition, metabolism assay with rat liver microsomes demonstrated that GA reduced the formation of metabolic activation-derived pyrrole-glutathione conjugate in a dose-dependent manner with the estimated IC value of 5.07 µM. Further mechanism study showed that GA inhibited activities of CYPs, especially CYP3A1, the major CYP isoform responsible for the metabolic activation of RTS in rats. Enzymatic kinetic study revealed a competitive inhibition of rat CYP3A1 by GA. In conclusion, our findings demonstrated that both EX and GA exhibited significant hepato-protective effects against RTS-induced hepatotoxicity, mainly through the competitive inhibition of CYP-mediated metabolic activation of RTS.

Keywords

References

  1. Food Chem Toxicol. 2020 Jan;135:110868 [PMID: 31586656]
  2. Chem Res Toxicol. 2021 Apr 19;34(4):1101-1113 [PMID: 33719395]
  3. Pharmazie. 2000 Oct;55(10):711-26 [PMID: 11082830]
  4. Nucleic Acids Res. 2011 Jul;39(Web Server issue):W270-7 [PMID: 21624888]
  5. J Gastroenterol Hepatol. 2019 Apr;34(4):634-642 [PMID: 30669184]
  6. Food Chem Toxicol. 2020 Feb;136:111107 [PMID: 31904473]
  7. Arch Toxicol. 2021 Feb;95(2):759-765 [PMID: 33210216]
  8. Medicines (Basel). 2020 Sep 29;7(10): [PMID: 33003400]
  9. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2014;31(11):1886-95 [PMID: 25222912]
  10. Plants (Basel). 2021 Dec 14;10(12): [PMID: 34961221]
  11. Arch Toxicol. 2021 Jun;95(6):1917-1942 [PMID: 34003343]
  12. Arch Toxicol. 2021 Jan;95(1):103-116 [PMID: 33033841]
  13. Arch Toxicol. 2020 Sep;94(9):3281-3295 [PMID: 32518961]
  14. J Hepatol. 2011 Apr;54(4):666-73 [PMID: 21146894]
  15. Hepatology. 2021 Jul;74(1):264-280 [PMID: 33462832]
  16. World J Gastroenterol. 2007 Mar 14;13(10):1628-31 [PMID: 17461462]
  17. Drug Metab Dispos. 2002 Jun;30(6):709-15 [PMID: 12019199]
  18. J Toxicol. 2010;2010:313280 [PMID: 20652038]
  19. Front Pharmacol. 2019 Jan 22;10:13 [PMID: 30723409]
  20. J Pharm Pharmacol. 1996 Sep;48(9):902-5 [PMID: 8910850]
  21. Phytomedicine. 2021 Aug;89:153595 [PMID: 34153877]
  22. Food Chem Toxicol. 2018 May;115:63-72 [PMID: 29524571]
  23. Semin Liver Dis. 2002 Feb;22(1):27-42 [PMID: 11928077]
  24. Front Pharmacol. 2021 Sep 24;12:701240 [PMID: 34630081]
  25. Chem Biol Interact. 2016 Jan 5;243:119-26 [PMID: 26365561]
  26. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2015;33(4):404-21 [PMID: 26398275]
  27. Biol Pharm Bull. 2007 Oct;30(10):1898-904 [PMID: 17917259]
  28. J Cardiovasc Pharmacol. 1997 Jul;30(1):124-9 [PMID: 9268231]
  29. Drug Metab Dispos. 2016 May;44(5):720-31 [PMID: 26965985]
  30. Lancet. 1976 Aug 7;2(7980):269-71 [PMID: 59848]
  31. J Food Drug Anal. 2015 Sep;23(3):577-586 [PMID: 28911718]
  32. Pharmacol Toxicol. 1997 Dec;81(6):300-2 [PMID: 9444673]
  33. Toxicon. 1999 Sep;37(9):1259-70 [PMID: 10400287]
  34. Chem Res Toxicol. 2014 Jun 16;27(6):1030-9 [PMID: 24836403]
  35. J Dig Dis. 2012 Jan;13(1):33-9 [PMID: 22188914]
  36. Int J Environ Res Public Health. 2015 Dec 25;13(1):84 [PMID: 26712778]
  37. Drug Metab Lett. 2011 Jan;5(1):17-24 [PMID: 21198441]
  38. Chem Res Toxicol. 2017 Jan 17;30(1):81-93 [PMID: 28092947]
  39. Drug Metab Dispos. 2000 Dec;28(12):1475-83 [PMID: 11095586]
  40. Hepatology. 1999 Jun;29(6):1779-91 [PMID: 10347121]
  41. Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13682-7 [PMID: 16954191]
  42. Lancet. 1976 Aug 7;2(7980):271-2 [PMID: 59849]
  43. Acta Pharmacol Sin. 2021 Aug;42(8):1212-1222 [PMID: 33154553]
  44. Int J Mol Sci. 2015 Dec 24;17(1): [PMID: 26712744]
  45. J Ethnopharmacol. 2013 Dec 12;150(3):781-90 [PMID: 24201019]
  46. Arch Toxicol. 2017 Dec;91(12):3913-3925 [PMID: 28620673]
  47. Regul Toxicol Pharmacol. 2006 Dec;46(3):167-92 [PMID: 16884839]
  48. Phytother Res. 2011 Oct;25(10):1429-34 [PMID: 21351298]
  49. Experientia. 1989 Sep 15;45(9):896-8 [PMID: 2776861]
  50. Life Sci. 2005 Jan 21;76(10):1167-76 [PMID: 15620580]
  51. Hepatology. 2008 Jun;47(6):1905-15 [PMID: 18452148]
  52. Toxicology. 2014 Aug 1;322:34-42 [PMID: 24799337]
  53. Chem Res Toxicol. 2019 Jun 17;32(6):1027-1039 [PMID: 31012303]
  54. Acta Pharmacol Sin. 2021 Jan;42(1):18-26 [PMID: 32144337]
  55. Int J Mol Sci. 2021 Sep 27;22(19): [PMID: 34638760]
  56. Biol Pharm Bull. 2005 Oct;28(10):2000-2 [PMID: 16204965]

Word Cloud

Created with Highcharts 10.0.0GAliverreductionmetabolicactivationformationEXratadductshepato-protectivestudydemonstratedRTSplasmacompetitiveinhibitionpyrrolizidinealkaloidPAcasesPA-inducedcytochromeP450CYPLiquoricemedicineeffectsliquorice18β-glycyrrhetinicacidhepatotoxicitymechanismsingle-multiple-treatmentsignificantlypyrrole-proteinreduced305%rats1%CYP3A1Misuse-containingplantsconsumptionPA-contaminatedfoodstuffscausesnumerouspoisoninghumansyearlyeffectivetherapeuticstrategiesstilllimitedinjuryinitiated-mediatedsubsequentcellularproteinsherbalcommonlyusedconcurrentlyPA-containingherbsmanycompoundtraditionalChineseformulasPA-poisoningreportedcombinationpresentaimedinvestigateaqueousextractprimarybioactiveconstituentunderlyingHistopathologicalbiochemicalanalysis500 mg/kg50 mg/kgattenuateddamagecausedretrorsinerepresentativehepatotoxic3%508%multiple-3256treatmentSingle-alsodecreased23151853respectivelyadditionmetabolismassaymicrosomesactivation-derivedpyrrole-glutathioneconjugatedose-dependentmannerestimatedICvalue507 µMshowedinhibitedactivitiesCYPsespeciallymajorisoformresponsibleEnzymatickineticrevealedconclusionfindingsexhibitedsignificantRTS-inducedmainlyCYP-mediatedExtract18β-GlycyrrhetinicAcidProtectExperimentalPyrrolizidineAlkaloid-InducedHepatotoxicityRatsInhibitingCytochromeP450-MediatedMetabolicActivation

Similar Articles

Cited By